Technology & Science
Feb. 9, 2010
Investors Profit From Biotech Bankruptcy
Biotechs and bankruptcy - not a common duo. But these days, bankruptcy can seem like an attractive option, especially considering all the shrinking alternatives for investors.
Daily Journal Staff Writer
Biotechs and bankruptcy don't often go together. But that may be changing, according to some industry observers.
"I have never seen companies file for bankruptcy as much as I have now," said Colleen Sproul, a principal at Contracts Associates Inc., a Boston-based firm that outsources legal consultants to life science companies.
Many biotechs today, however,...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In